Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
Industries
  • Fintech
  • AI
  • Health Tech
About
Compound is a thesis-driven, research-centric investment firm based in NYC. They lead seed rounds and invest in bleeding-edge technology built by outliers.
Min check size
$100K
Max check size
$3M
Fund size
NPS

Investment Thesis

Compound invests in early stage technology startups, particularly those focused on solving complex problems through innovations in fintech, cybersecurity, and digital infrastructure.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a solid track record in venture capital, the fund manager has participated in over 40 investments across technology and healthcare sectors, primarily targeting early-stage opportunities in the North American market. Their strategic approach is characterized by a data-driven analysis, enabling the identification of high-potential startups that align with emerging trends. Notable exits from their portfolio include successful companies in fintech and life sciences, showcasing a knack for backing transformative ventures. This operator-first mindset underscores their commitment to supporting founders while leveraging industry connections to drive growth.

Compound Contacts Information

Primary contact

Secondary contact

Team

Taro Kawamura

Nora Nora Rodriguez

David Hirsch

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp